06/02/2012Cancer cases will rise by 30 per cent in the UK by 2030
Experts warn that new cases of cancer could rise by 30 per cent in the UK by 2030, due to unhealthy lifestyle choices and an ageing population. The UK has been ranked 16th out of 27 countries in the...03/02/2012Bupa, AXA PPP, WPA and Aviva will cover prostate cancer drug Abiraterone
After we previously reported that prostate cancer drug abiraterone has been deemed by NICE as too expensive for use on the NHS, health insurers are now coming forward to offer cover for the drug. NICE had...03/02/2012Pre-sliced watermelons from Brazil linked to deadly salmonella outbreak
A deadly salmonella outbreak has been linked to pre-sliced watermelons from Brazil, says the Health Protection Agency. Since December, one person has died and 50 more have fallen ill with a Salmonella Newport...03/02/2012Patients are more likely to die in an NHS hospital at the weekend
A large scale study has shown that you are more likely to die if you are taken into hospital at the weekend. Researchers from University College London, commissioned by the Department of Health, looked at...02/02/2012'Promising' breast cancer vaccine uses immune system to fight the disease
A vaccine to treat breast cancer using a patient’s own cells has been developed by scientists, with promising results. Researchers at the University of Pennsylvania looked at 27 patients suffering from a...02/02/2012USA300, deadly strain of superbug MRSA, increasing in the UK
Potentially deadly strains of MRSA that can be passed between people outside of hospitals are increasing in the UK, warn experts. In a new research paper published in the Journal of Infectious Diseases,...02/02/2012Prostate cancer drug Abiraterone turned down by NICE, but available for patients with private medical cover
Abiraterone, a drug that extends the life of prostate cancer sufferers, has been provisionally rejected for use on the NHS. However, it will still be available to patients with private medical insurance . ...